These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 26894297)

  • 41. Glucose-6-phosphate dehydrogenase deficiency prevalence and genetic variants in malaria endemic areas of Colombia.
    Valencia SH; Ocampo ID; Arce-Plata MI; Recht J; Arévalo-Herrera M
    Malar J; 2016 May; 15(1):291. PubMed ID: 27225440
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Investigation of glucose-6-phosphate dehydrogenase (G6PD) deficiency prevalence in a Plasmodium vivax-endemic area in the Republic of Korea (ROK).
    Lee W; Lee SE; Lee MJ; Noh KT
    Malar J; 2020 Sep; 19(1):317. PubMed ID: 32873296
    [TBL] [Abstract][Full Text] [Related]  

  • 43. G6PD deficiency alleles in a malaria-endemic region in the Western Brazilian Amazon.
    Dombrowski JG; Souza RM; Curry J; Hinton L; Silva NRM; Grignard L; Gonçalves LA; Gomes AR; Epiphanio S; Drakeley C; Huggett J; Clark TG; Campino S; Marinho CRF
    Malar J; 2017 Jun; 16(1):253. PubMed ID: 28619120
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cost-effectiveness analysis of rapid diagnostic tests for G6PD deficiency in patients with Plasmodium vivax malaria in the Brazilian Amazon.
    Peixoto HM; Brito MA; Romero GA; Monteiro WM; de Lacerda MV; de Oliveira MR
    Malar J; 2016 Feb; 15():82. PubMed ID: 26864333
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevalence and hematological indicators of G6PD deficiency in malaria-infected patients.
    Kotepui M; Uthaisar K; PhunPhuech B; Phiwklam N
    Infect Dis Poverty; 2016 Apr; 5():36. PubMed ID: 27109515
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Malaria and glucose-6-phosphate dehydrogenase deficiency in North Sumatra, Indonesia.
    Matsuoka H; Ishii A; Panjaitan W; Sudiranto R
    Southeast Asian J Trop Med Public Health; 1986 Dec; 17(4):530-6. PubMed ID: 3576282
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Comparison of Three Quantitative Methods to Estimate G6PD Activity in the Chittagong Hill Tracts, Bangladesh.
    Ley B; Alam MS; O'Donnell JJ; Hossain MS; Kibria MG; Jahan N; Khan WA; Thriemer K; Chatfield MD; Price RN; Richards JS
    PLoS One; 2017; 12(1):e0169930. PubMed ID: 28121993
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of G6PD genotypes and phenotypes on the northwestern Thailand-Myanmar border.
    Bancone G; Chu CS; Somsakchaicharoen R; Chowwiwat N; Parker DM; Charunwatthana P; White NJ; Nosten FH
    PLoS One; 2014; 9(12):e116063. PubMed ID: 25536053
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risk of hemolysis in Plasmodium vivax malaria patients receiving standard primaquine treatment in a population with high prevalence of G6PD deficiency.
    Liu H; Zeng W; Malla P; Wang C; Lakshmi S; Kim K; Menezes L; Yang Z; Cui L
    Infection; 2023 Feb; 51(1):213-222. PubMed ID: 35976559
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Global economic costs due to vivax malaria and the potential impact of its radical cure: A modelling study.
    Devine A; Battle KE; Meagher N; Howes RE; Dini S; Gething PW; Simpson JA; Price RN; Lubell Y
    PLoS Med; 2021 Jun; 18(6):e1003614. PubMed ID: 34061843
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cost-effectiveness analysis of G6PD diagnostic test for Plasmodium vivax radical cure in Lao PDR: An economic modelling study.
    Aung YN; Tun STT; Vanisaveth V; Chindavongsa K; Kanya L
    PLoS One; 2022; 17(4):e0267193. PubMed ID: 35468145
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevalence of glucose-6-phosphate dehydrogenase (G6PD) deficiency among malaria patients in Upper Myanmar.
    Lee J; Kim TI; Kang JM; Jun H; Lê HG; Thái TL; Sohn WM; Myint MK; Lin K; Kim TS; Na BK
    BMC Infect Dis; 2018 Mar; 18(1):131. PubMed ID: 29548282
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Understanding human genetic factors influencing primaquine safety and efficacy to guide primaquine roll-out in a pre-elimination setting in southern Africa.
    Awandu SS; Raman J; Makhanthisa TI; Kruger P; Frean J; Bousema T; Niemand J; Birkholtz LM
    Malar J; 2018 Mar; 17(1):120. PubMed ID: 29558929
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dynamics of G6PD activity in patients receiving weekly primaquine for therapy of Plasmodium vivax malaria.
    Taylor WRJ; Kim S; Kheng S; Muth S; Tor P; Christophel E; Mukaka M; Kerleguer A; Luzzatto L; Baird JK; Menard D
    PLoS Negl Trop Dis; 2021 Sep; 15(9):e0009690. PubMed ID: 34495956
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevalence and genetic variants of G6PD deficiency among two Malagasy populations living in Plasmodium vivax-endemic areas.
    Howes RE; Chan ER; Rakotomanga TA; Schulte S; Gibson J; Zikursh M; Franchard T; Ramiranirina B; Ratsimbasoa A; Zimmerman PA
    Malar J; 2017 Apr; 16(1):139. PubMed ID: 28376871
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The risk of adverse clinical outcomes following treatment of Plasmodium vivax malaria with and without primaquine in Papua, Indonesia.
    Thriemer K; Poespoprodjo JR; Kenangalem E; Douglas NM; Sugiarto P; Anstey NM; Simpson JA; Price RN
    PLoS Negl Trop Dis; 2020 Nov; 14(11):e0008838. PubMed ID: 33175835
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The prevalence of glucose-6-phosphate dehydrogenase deficiency in the Cape Verdean population in the context of malaria elimination.
    DePina AJ; Pires CM; Andrade AJB; Dia AK; Moreira AL; Ferreira MCM; Correia AJ; Faye O; Seck I; Niang EHA
    PLoS One; 2020; 15(3):e0229574. PubMed ID: 32176714
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevalence and molecular basis of glucose-6-phosphate dehydrogenase deficiency in Afghan populations: implications for treatment policy in the region.
    Leslie T; Moiz B; Mohammad N; Amanzai O; Ur Rasheed H; Jan S; Siddiqi AM; Nasir A; Beg MA; Vink M
    Malar J; 2013 Jul; 12():230. PubMed ID: 23834949
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Glucose-6-phosphate dehydrogenase activity in individuals with and without malaria: Analysis of clinical trial, cross-sectional and case-control data from Bangladesh.
    Ley B; Alam MS; Kibria MG; Marfurt J; Phru CS; Ami JQ; Thriemer K; Auburn S; Jahan N; Johora FT; Hossain MS; Koepfli C; Khan WA; Price RN
    PLoS Med; 2021 Apr; 18(4):e1003576. PubMed ID: 33891581
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Wide range of G6PD activities found among ethnic groups of the Chittagong Hill Tracts, Bangladesh.
    Ley B; Kibria MG; Khan WA; Auburn S; Phru CS; Jahan N; Johora FT; Thriemer K; Ami JQ; Hossain MS; Price RN; Koepfli C; Alam MS
    PLoS Negl Trop Dis; 2020 Sep; 14(9):e0008697. PubMed ID: 32925910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.